Bausch Health Companies Inc. (NYSE:BHC) will be discussing 3Q20 financial results with the investment community.on 3rd November 2020 at 8:00 AM eastern time.
Those interested in listening to the conference call live via the Internet can visit www.bauschhealth.com
Earnings Expectation
Bausch Health Companies Inc. is set to announce third quarter earning results on Tuesday 3rd November 2020, before market open.
Analysts surveyed by Thomson Reuters are predicting, BHC to report 3Q20 income of $ 1.04 per share. For the full year, analysts anticipate top line of $ 7887.71 million, while looking forward to income of $ 3.64 per share bottom line.
The Company Outlook
Revenue for 3Q20 are expected in a range of $ 2,100.00 million ~ $ 2,100.00 million
Full Year 2020 topline are forecasted in a range of$ 7,800.00 million ~ $ 8,000.00 million
Click Here For More Historical Outlooks Of Bausch Health Companies Inc.
Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through four segments: Bausch + Lomb/International, Salix, Ortho Dermatologics, and Diversified Products.
